Global /India /Healthcare /Drug Manufacturers - General /524516

Bacil Pharma Ltd.

524516 (BACPHAR)

• BSE: 524516 • Delayed

57.42INR 2.6%

0.6081 USD

As of 20 June 2026, Bacil Pharma Ltd. has a market cap of $8.73M USD, ranking #42011 globally and #3395 in India. It ranks #3719 in the Healthcare sector, and #1208 in the Drug Manufacturers - General industry.

Global Rank

42011

Country Rank

3395

Sector Rank

3719

Industry Rank

1208

Key Stats

Market Cap

$8.73MUSD

824.15M INR

Enterprise Value

$8.56MUSD

808.21M INR

EBITDA (TTM)

-$25.6KUSD

-2.42M INR

Net Income (TTM)

$78.16KUSD

7.38M INR

PE Ratio

95.8

PB Ratio

3.1

Company Profile

Country (HQ)

India

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Ganpat Salekar open_in_new

Employees

Founded

1987

Website

bacilpharma.co.in open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
2.6%	-5.1%	22%	45%	39%	57%	35%	852%	867%

News

Markets

Exchange	Ticker	Price	Quotes
Bombay Stock Exchange (BSE / BOM) MIC: XBOM PRIMARY	524516 (BACPHAR) Bacil Pharma Ltd ISIN: INE711D01018 Shares Out.: Shares Outstanding: 14.353M¹ TV: TradingView: BSE: BACPHAR SA: Stock Analysis: BOM: 524516 YF: Yahoo Finance: 524516.BO GF: Google Finance: BOM: 524516 BA: Barron's: 524516 MS: Morningstar: XBOM: 524516	57.42 INR	TV: TradingView: BSE: BACPHAR SA: Stock Analysis: BOM: 524516 YF: Yahoo Finance: 524516.BO GF: Google Finance: BOM: 524516 BA: Barron's: 524516 MS: Morningstar: XBOM: 524516

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Bacil Pharma Ltd.

Bacil Pharma Limited develops, manufactures, and distributes pharmaceuticals products in India. The company offers tablets, capsules, injectables, ointments, and specialty products. Bacil Pharma Limited was incorporated in 1987 and is based in Mumbai, India.

Similar Companies

Industry: Drug Manufacturers - General (India)

Name	Market Cap (USD) diff.	PE	Country
Sun Pharmaceutical Industries Ltd. NSE: SUNPHARMA	$45.22B 4.27T INR 518K%	39.1	India
Divi's Laboratories Ltd. NSE: DIVISLAB	$18.38B 1.73T INR 210K%	70.0	India
Torrent Pharmaceuticals Ltd. NSE: TORNTPHARM	$15.17B 1.43T INR 174K%	63.0	India
Dr. Reddy's Laboratories Ltd. NSE: DRREDDY	$11.73B 1.11T INR 134K%	19.6	India
Mankind Pharma Ltd. NSE: MANKIND	$9.87B 931.67B INR 113K%	52.2	India
Zydus Lifesciences Ltd. NSE: ZYDUSLIFE	$9.71B 916.53B INR 111K%	18.6	India

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 9M%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 6M%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 4M%	97.4	United States
Roche Holding AG SIX: RO	$318.3B 256.25B CHF 4M%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$284.64B 215.59B GBP 3M%	27.6	United Kingdom
Merck & Co., Inc. NYSE: MRK	$274.03B 3M%	15.1	United States

chevron_leftBack